CORC

在结果中检索

CORC

浏览/检索结果: 共559条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Progress of Lattice Design and Physics Studies on the High Energy Photon Source 会议论文
Brazil, 2021
作者:  Y. Jiao;  Y. Bai;  X. Cui;  C.C. Du;  Z. Duan
收藏  |  浏览/下载：13/0  |  提交时间：2022/01/18
Adjustment of optical axis consistency of spatial rotation in laser coupling 会议论文
Beijing, China, 2021-06-20
作者:  Cao, Ming Qiang;  Li, Xiao Yan;  Hou, Xiao Hua;  Zhang, Ge;  Lei, Yu
收藏  |  浏览/下载：16/0  |  提交时间：2022/01/30
Development of a Long Range Autonomous Underwater Vehicle for Ocean Observation 会议论文
Biloxi, MS, United states, October 5-30, 2020
作者:  Li JX(李吉旭);  Liu TJ(刘铁军);  Yu DY(于得勇);  Yan XY(闫兴亚);  Gao TZ(郜天柱)
收藏  |  浏览/下载：8/0  |  提交时间：2021/05/10
Progress of Lattice Design and Physics Studies on the High Energy Photon Source 会议论文
Australia, 2019
作者:  Y. Jiao;  X. Cui;  Z. Duan;  Y.Y. Guo;  P. He
收藏  |  浏览/下载：33/0  |  提交时间：2019/08/06
Beam Dynamics Study in the HEPS Storage Ring 会议论文
Australia, 2019
作者:  Y. Jiao;  X. Cui;  Z. Duan;  Y.Y. Guo;  P. He
收藏  |  浏览/下载：34/0  |  提交时间：2019/08/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
MKL1 and STAT3 activate the activity of the luciferase reporter plasmid containing the CAAP1 gene promoter (Open Access) 会议论文
作者:  Li, Jun-Yan;  Yu, Zhu;  Wang, Feng-Yun
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace